Exchange: NASDAQ·Updated 04:00 PM EDT

BLSM BlossomHill Therapeutics Inc..

$16.88
$0.27
(1.63%)
Today
Reported EarningsSep 18
Mkt Cap$527.95M
Vol165,151.00

About BLSM

Blossomhill Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded on June 22, 2020 and is headquartered in San Diego, CA.
48

Neutral Sentiment

How do you feel about BLSM?

Advertisement|Remove ads.